Vance backs US-Iran deal as Washington ends blockade and Iran hails wartime gains.
The "Queen of Country Pop" is giving fans new music before the release of her highly antic...
Behind the mounting evidence of crimes against Palestinians are the lawyers braving harass...
The mother of Cape Verde’s star goalkeeper Vozinha has been granted a visa to enter the Un...
You'll need to brush up on some classic sports terms in order to solve today's NYT Connect...
Countries
Opinion
Juneteenth: A reminder that affirmative action undermines equality
- NY Times News ( Middle East ) 2026/4/30
David Ricks, chief executive officer of Eli Lilly & Co., at the Semafor World Economy Summit during the International Monetary Fund (IM...
- Independent ( Yemen ) 2026/4/2
The FDA authorized Eli Lilly's drug as part of a new program aimed at cutting drug approval times
- PR Newswire ( Middle East ) 2026/3/28
Taltz and Zepbound used together provided comprehensive improvements in disease activity and patient-reported outcomes compared to Taltz mon...
- Gizmodo ( Middle East ) 2026/1/9
People who took both Zepbound and an anti-inflammatory drug saw a greater improvement of their psoriatic arthritis symptoms.
- Quartz ( Middle East ) 2025/10/6
European Association for the Study of Obesity says the drugs are so effective, they should be used for almost all obesity patients
- Los Angeles Daily News ( Middle East ) 2025/5/12
By Naomi Kresge | BloombergEli Lilly & Co.’s obesity drug Zepbound helped people trim about two inches more off their waists than Novo Nord...
- Quartz ( Middle East ) 2025/5/12
Eli Lilly’s (LLY) and Novo Nordisk’s (NVO) weight loss drugs went head-to-head in a weight loss study for the first time — and Eli Lilly’s d...
- News10NBC ( Middle East ) 2025/5/12
People taking Eli Lilly’s obesity drug, Zepbound, lost nearly 50% more weight than those using rival Novo Nordisk’s Wegovy in the first head...
- Quartz ( Middle East ) 2025/4/1
Eli Lilly (LLY) is taking legal action against makers of off-brand versions of its blockbuster diabetes and weight-loss drugs, Mounjaro and...
- Ukiah Daily Journal ( Middle East ) 2025/3/5
Makers of the popular obesity treatments Wegovy and Zepbound are cutting prices for people without insurance.Related ArticlesHealth |...